SEC Form 4 · accession 0001179110-15-012974
HOSPIRA INC · HSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
F Michael Ball
Officer — Chief Executive Officer · Director
Period of report
Sep 3, 2015
Accepted (ET)
Sep 3, 2015 · 11:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 3, 2015 | A | 36,691 | $0.00 | A | 361,441 | D | |
| Common Stock | Sep 3, 2015 | A | 65,227 | $0.00 | A | 426,668 | D | |
| Common Stock | Sep 3, 2015 | A | 48,263 | $0.00 | A | 474,931 | D | |
| Common Stock | Sep 3, 2015 | M | 152,458 | $55.29 | A | 627,389 | D | |
| Common Stock | Sep 3, 2015 | M | 231,537 | $35.36 | A | 858,926 | D | |
| Common Stock | Sep 3, 2015 | M | 140,000 | $35.36 | A | 998,926 | D | |
| Common Stock | Sep 3, 2015 | M | 235,772 | $28.95 | A | 1,234,698 | D | |
| Common Stock | Sep 3, 2015 | M | 177,778 | $42.70 | A | 1,412,476 | D | |
| Common Stock | Sep 3, 2015 | D | 1,412,476 | $90.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F4 | $55.29 | Sep 3, 2015 | M | 152,458 | D | — | Mar 30, 2018 | Common Stock | 152,458 | 0 | D |
| Stock Options (right to buy)F5 | $35.36 | Sep 3, 2015 | M | 231,537 | D | — | Feb 28, 2019 | Common Stock | 231,537 | 0 | D |
| Stock Options (right to buy)F6 | $35.36 | Sep 3, 2015 | M | 140,000 | D | — | Feb 28, 2017 | Common Stock | 140,000 | 0 | D |
| Stock Options (right to buy)F7 | $28.95 | Sep 3, 2015 | M | 235,772 | D | — | Feb 26, 2020 | Common Stock | 235,772 | 0 | D |
| Stock Options (right to buy)F8 | $42.70 | Sep 3, 2015 | M | 177,778 | D | — | Feb 25, 2021 | Common Stock | 177,778 | 0 | D |
Explanation of responses
- F1Vesting of performance share units for the 2014-2016 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
- F2Vesting of performance share units for the 2013-2015 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
- F3Vesting of a performance-contingent restricted stock units award granted February 27, 2013. The units were earned when Hospira's stock price appreciated 20% over the fair market value on the date of grant, and maintained that price for a 30 consecutive trading day period (based on Hospira's closing market price on those 30 consecutive days). Since the units were earned, the award provided for three-year time based cliff vesting, or a change of control. Thus, vesting of the units was accelerated upon a change of control.
- F4Exercise of stock options granted on 3/31/2011, which vested in three equal installments on March 31, 2012, 2013 and 2014.
- F5Exercise of 231,537 stock options granted on 3/1/2012, which vested in four equal installments on March 1, 2013, 2014, 2015, and 2016. The vesting of the last tranche of options was accelerated in connection with the change of control.
- F6Exercise of 140,000 performance stock options granted on 3/1/2012, which had a five year term. The options vested and became exercisable when the average stock price over a thirty consecutive day period was at or above the vesting trigger price. For half of the options, the vesting trigger price was $42.26, which was based on the closing stock price on March 1, 2012 plus 19%. For the other half of the options, the vesting trigger price was $47.58, which was based on the closing stock price on March 1, 2012 plus 34%.
- F7Exercise of stock options granted on 2/27/2013, which vest in four annual installments on February 27, 2014, 2015, 2016 and 2017. The vesting of the last two tranches of options was accelerated in connection with the change of control.
- F8Exercise of stock options granted on 2/26/2014, which vest in four annual installments on February 26, 2015, 2016, 2017 and 2018. The vesting of the last three tranches of options was accelerated in connection with the change of control.
Remarks
Updating Power of Attorney to reflect changes in staff.